Change in body mass index among girls with precocious puberty under treatment

被引：9

作者：

Zurita Cruz, Jessie N. ^{[2
]}

Diaz Rodriguez, Irene ^{[1
]}

NishimuraMeguro, Elisa ^{[1
]}

VillasisKeever, Miguel A. ^{[2
]}

De Jesus Rivera Hernandez, Aleida ^{[1
]}

Garrido Magana, Eulalia ^{[1
]}

机构：

[1] Children Hosp, Ctr Med Nacl Siglo 21, Mexican Social Secur Inst, Inst Mexicano Seguro Social,Dept Pediat Endocrino, Ciudad De Mexico, Mexico

[2] Children Hosp, UMAE,Ctr Med Nacl Siglo 21, Mexican Social Secur Inst,High Specialty Med Unit, Inst Mexicano Seguro Social,Unit Med Res Clin Epi, Ciudad De Mexico, DF, Mexico

来源：

ARCHIVOS ARGENTINOS DE PEDIATRIA | 2016年 / 114卷 / 02期

关键词：

central precocious puberty; body mass index; obesity; leuprolide; GONADOTROPIN-SUPPRESSIVE THERAPY; HORMONE AGONIST; OBESITY; ANALOGS; HEIGHT; GROWTH;

D O I：

10.5546/aap.2016.eng.143

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Introduction: Changes in body mass index (BMI) among girls with idiopathic central precocious puberty (ICPP) under treatment have been controversial in other populations. Objective: To assess changes in BMI Z score and the rate of overweight and obesity in Mexican girls with ICPP during their first year of treatment. Methodology: A retrospective study was conducted among girls with ICPP under treatment with leuprolide, with a somatometry performed every six months, over a 1-year period. An analysis of variance (ANOVA) was done to establish differences in BMI Z score and a multivariate analysis was used to assess the relationship among the different factors. Results: Among 121 girls, BMI Z score increased from 0.87 to 1.32, and the rate of overweight and obesity increased from 40.5% to 70.3%, a statistically significant difference. Conclusions: Changes in BMI Z score and the rate of overweight and obesity among Mexican girls with ICPP increased significantly.

引用

页码：143 / 146

页数：4

共 14 条

[1]

Aguiar AL, 2006, J PEDIATR ENDOCR MET, V19, P1327

[2] Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty [J].